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Podocyte cell cycle regulation and proliferation in collapsing level of G1 phase, the duration of which is variable in each
glomerulopathies. cell type. Once cells have passed through the restriction
Background. Mature podocytes are growth-arrested be- point at the end of G1, they enter the S phase, and DNAcause of the expression of cyclin-dependent kinase inhibitors.
is synthesized. The cell cycle can be arrested at severalUnder pathological conditions, podocytes may undergo mito-
checkpoints [1–3], leading to duplication or repair of thesis, but not cell division. Exceptions to this rule are collapsing
glomerulopathies (CGs), including HIV-associated nephropa- DNA without mandatory mitosis. Cell cycle completion
thy (HIVAN) and idiopathic CG, where podocytes undergo a is under the control of alternate expression of cyclins
dysregulation of their differentiated phenotype and proliferate.
and CKI. Cyclins D and E are responsible for the progres-Methods. To shed light on the mechanism underlying podo-
sion of the cell cycle from the G1 to the S phase, whereascyte proliferation in CG, we analyzed the expression of the
proliferation marker Ki-67, cyclins (A, D1), cyclin-dependent cyclins A and B promote the S/G2/M phase. Cyclin ex-
kinase inhibitors (p27, p57), and podocyte differentiation marker pression is negatively regulated by CKIs, including p21,
synaptopodin in eight cases of HIVAN and two cases of idio- p27, and p57.pathic CG. Normal fetal and adult kidneys served as controls.
The ability of podocytes to proliferate depends on theirResults. Both HIVAN and idiopathic CG showed a marked
state of differentiation. During glomerulogenesis, imma-reduction in the expression of p27, p57, and cyclin D1 (absent
in 69, 62, and 80% of all glomeruli, respectively). Cyclin A and ture podocyte precursor cells undergo marked prolifera-
Ki-67 were expressed in 11 and 29% of all glomeruli. Moreover, tion [4]. However, as podocytes mature, they become
there was partial loss of synaptopodin and cyclin D1 expression terminally differentiated, a phenotype that is quiescentin nonaffected glomeruli.
[4–6]. Normal mature podocytes express CKI p27 andConclusions. The loss of p27 and p57 leading to expression
of cyclin A may account for the activation of podocyte prolifer- p57 and cyclin D1, indicating that they are in a state that
ation in CG. Furthermore, the loss of cyclin D1 from histologi- precedes the first check point in the cell cycle [5]. In
cally normal glomeruli suggests a possible role of cyclin D1 in contrast to the marked proliferation that follows many
mediating the dysregulation of the podocyte cell cycle in CG.
forms of mesangial and endothelial cell damage, damageThese novel findings offer insight into the molecular regulation
to mature podocyte is associated with a relative lack ofof mature podocyte differentiation. Podocyte proliferation in
CG provides evidence in support of a previously underesti- proliferation [7–9]. Podocytes are injured in many forms
mated plasticity of mature podocytes. of glomerular disease, including diseases that are immune
mediated (membranous glomerulopathy), toxin associ-
ated (puromycin aminonucleoside model of minimal
The cell cycle is regulated by a balance of positive (cy- change nephropathy), metabolic (diabetes), and hemo-
clins) and negative [cyclin-dependent kinase inhibitors dynamic (glomerular hyperfiltration). In most glomeru-
(CKIs)] cell cycle regulatory proteins [1–3]. Under ap- lar diseases, podocytes may undergo DNA synthesis and
propriate stimuli, cells may re-enter the cell cycle at the mitosis, but not cytokinesis [7–9]. Failure to replicate
leads to an inappropriate response of podocytes to injury
resulting in progressive glomerulosclerosis [7, 8]. TheKey words: HIV-associated nephropathy, cyclin-dependent kinase
inhibitor, Ki-67, p27 and p57, microcysts, tubulointerstitial damage. effective restriction of podocyte proliferation, even un-
der pathological conditions, is mediated by the expres-Received for publication November 4, 1999
sion of high levels of p27 and p57 [9]. In a recent study,and in revised form January 10, 2000
Accepted for publication February 1, 2000 we have shown that, in contrast to other glomerular
diseases, in collapsing glomerulopathies (CGs; both idio-Ó 2000 by the International Society of Nephrology
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pathic and HIV associated), the increase in glomerular sclerosis was quantitated as the percentage of affected
glomeruli per total number of glomeruli. In addition,cellularity is a consequence of podocyte proliferation
[10]. Moreover, we showed that in CG podocytes not the average number of podocytes per glomerulus was
calculated among all glomeruli except for the globallyonly undergo dedifferentiation, reflected by the loss of
maturity markers such as synaptopodin, but also a phe- sclerotic ones (because they are devoid of podocytes)
and compared with normal kidney. Semiquantitation ofnotypic dysregulation reflected by the loss of WT-1, a
transcription factor normally expressed throughout all the tubular interstitial damage (TID) was also performed
using a scale from 0 to 31 [0, 11 (#25%), 21 (.25% butstages of podocyte development [10].
The aim of the present study was to investigate the #50%), 31 (.50%)]. The presence of dilated tubules
(microcysts), a characteristic feature of CG, was evalu-molecular changes underlying podocyte replication in
CG. To this end, we analyzed the expression of cyclins ated separately from the TID. In addition, 3-mm thick
frozen sections were routinely stained for each case withand CKI in podocytes in HIV-associated nephropathy
(HIVAN) and idiopathic CG. We show that the loss of antibodies against IgG, IgA, IgM, C3, k, and l, according
to standard techniques.CKI p57 and p27 as well as the re-expression of cyclin A
and Ki-67 are restricted to podocytes overlying areas
Immunohistochemistryof collapse, indicating a re-entry of the cell cycle and
proliferation in areas of glomerular injury. Furthermore, The expression of synaptopodin and cell cycle proteins
was analyzed by immunohistochemistry on serial sectionswe demonstrate that the loss of cyclin D1 expression
occurs early in the disease before podocyte proliferation of kidney biopsies and control tissue using the streptavidin
biotin technique as previously described [5, 10]. Three-can be detected, suggesting a possible role of cyclin D1
in podocyte differentiation. micrometer thick sections of formalin-fixed and paraffin-
embedded tissues were microwaved for 25 minutes in 10
mmol/L sodium citrate buffer, pH 6.0. Sections were
METHODS
then incubated overnight at 48C with monoclonal antibod-
Selection of cases ies to synaptopodin (1:25) [14, 15], p27 (1:100; Transduc-
tion Laboratories, Lexington, KY, USA), Ki-67 (1:1000;Ten cases of CG, including eight HIVAN and two idio-
pathic CG, were selected from the archives of the Renal Novocastra Laboratories, Inc., Burlingame, CA, USA),
and cyclin D1 (1:100; Santa Cruz Biotechnology, SantaPathology laboratories at Montefiore Medical Center and
the University of Connecticut (Farmington, CT, USA). Cruz, CA, USA), and polyclonal antibodies to p57
(1:100) and cyclin A (1:200; both from Santa Cruz Bio-In addition, normal fetal kidney (obtain from therapeutic
abortion) and adult human kidneys (obtained from tu- technology). The specificity of the antibodies against
cyclin A, cyclin D1, p27, p57, and synaptopodin has pre-mor nephrectomies) were used as controls.
The age of the patients varied from 24 to 64 years viously been demonstrated by Western blot [5, 15]. Im-
munoreaction was visualized using 3,39-diaminobenzi-(mean, 45 years). Four patients were African Americans,
and three were Hispanic. In three cases, the race was dine as chromogen. Sections reacted with synaptopodin
were counterstained with hematoxylin, and sections re-unknown. Sixty percent of the patients were male. At
the time of the biopsy, proteinuria varied from 2.0 to acted with p27, p57, cyclin D1, cyclin A, and Ki-67 were
counterstained with periodic acid-Schiff reagent. Control8.4 g/day (mean, 5.0 g/day), and serum creatinine varied
from 1.0 to 15.0 mg/dL (mean, 4.7 mg/dL). experiments, in which the primary antibodies were re-
placed by normal mouse or rabbit serum, were consis-
Morphologic evaluation of biopsies tently negative.
The average number per glomerulus of podocytes withThree-micrometer thick sections of formalin-fixed tis-
sue were deparaffinized, rehydratated, and stained with loss of cyclin D1, p27, and p57 and re-expression of Ki-67
and cyclin A was calculated in segmentally and globallyhematoxilin and eosin, periodic acid Schiff, Jones’ silver,
and trichrome. Cases were reviewed and classified as collapsed glomeruli and in glomeruli with segmental scle-
rosis; completely sclerotic and obliterated glomeruli (de-HIVAN [11] or idiopathic CG according to previously
published definitions [12, 13] based on evaluation of glo- void of podocytes) were excluded.
merular, tubular, and interstitial damage (see Results or
morphologic analysis). Glomerular collapse was defined
RESULTS
as segmental or global wrinkling and folding of the glo-
Morphologic analysismerular basement membrane (GBM) with obliteration
of the glomerular capillaries, without increase of extra- Segmental or global wrinkling and folding of the GBM
with obliteration of glomerular capillaries were noted incellular matrix. Classic type of segmental and global glo-
merulosclerosis was also evaluated for each biopsy. The all cases. No mesangial expansion or intracapillary hyper-
cellularity was seen. Podocytes overlying collapsed anddegree of segmental and global glomerular collapse and
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contained proteinaceous material and hyperplastic podo-
cytes (Fig. 1b). The mean number of podocytes per glo-
merulus was more than double in CG (16.9 cells per
glomerulus) compared with normal kidney (7.8 cells per
glomerulus).
Podocyte hyperplasia led to the formation of “pseu-
docrescents,” which differ from true crescents because
they are composed of podocytes and do not contain
fibrin, inflammatory, or spindle cells typically found in
crescents. Moreover, the crowding podocytes forming
the “pseudocrescents” are separated from Bowman’s
capsule by the urinary space. Hyperplastic and hypertro-
phied podocytes occasionally detached from the GBM
and assumed a cuboidal shape (Fig. 1c). No synechiae
formation was seen between the collapsed capillaries
and Bowman’s capsule. Segmental and global sclerosis
(noncollapsing type), defined as scarring of the glomeru-
lar tuft, hyalinosis, and adhesions to Bowman’s capsule,
was also present.
Each biopsy contained at least 10 glomeruli (range,
10 to 83). The total number of glomeruli studied was
243. Segmental and global collapse was noted in 10 to
83% of the glomeruli when calculated in each biopsy
separately (mean 45%). In addition, segmental and
global sclerosis was present in 4 to 80% of the glomeruli
per each biopsy (mean 43%; Table 1).
No glomerular immunodeposits were seen in any of
the biopsies. Occasionally weak staining for IgM and C3
was present in the areas of sclerosis/collapse.
Tubular interstitial damage was defined as an asso-
ciation of tubular atrophy, tubular degenerative and re-
generative changes, interstitial fibrosis, and inflamma-
tion. Multiple tubules were markedly dilated, with flat-
tened epithelium and contained proteinaceous casts,
forming microcysts. Nine out of the 10 biopsies showed
moderate to severe (2 to 31) TID, and microcysts were
present in 80% of the cases. Mild arteriolosclerosis (11)
was present in 50% of the cases; the remaining 50%
showed a normal morphology of the vascular compart-
ment (Table 1).
Fig. 1. Glomerular morphology in HIV-associated nephropathy
(HIVAN). The glomerular lesions vary from focal (a) to global (b). (a)
Expression of synaptopodin and cell cycle proteins inThe glomerular tuft is segmentally collapsed (asterisks). The glomerular
capillaries are partially obliterated, and no extracellular matrix increase normal fetal and adult human kidney
is seen. The hypertrophied podocyte cell bodies are prominent, particu-
The expression of synaptopodin and the cell cyclelarly in the area of collapse. (b) In more advanced lesions, the collapse
is global involving the entire glomerular tuft. The GBM is folded and markers in normal fetal and adult human kidney was
wrinkled leading to an increase of Bowman’s space, which is filled with consistent with previously reported expression patterns
hypertrophic and hyperplastic podocytes containing protein reabsorp-
of these proteins [5–10]. Synaptopodin expression becametion droplets (arrowheads). (c) At higher magnification, details of the
altered podocyte morphology become obvious: Podocytes assume a first detectable at the transition from the late S-shaped
cuboidal shape and form a “crown” lining up along the outer aspect of body to the capillary loop-stage (data not shown) and
the collapsed GBM. The urinary space contains proteinaceous material.
increased thereafter to reach maximum levels in the ma-Silver staining. (a and b 3100, c 3200).
ture glomerulus (Fig. 2a). The expression of Ki-67, a
proliferation marker that recognizes all phases of thenoncollapsed capillaries were hypertrophied (Fig. 1a),
cell cycle from G1 to M, was particularly high in thewith large abundant cytoplasm containing prominent
comma- and S-shaped body stages and was drasticallyprotein reabsorption droplets (Fig. 1b). In globally col-
lapsed glomeruli, Bowman’s space was increased and reduced at the capillary loop stage when podocytes dif-
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Table 1. Morphologic analysis of glomerular, tubulointerstitial and vascular damage
N segm/global N segm/global
collapsed gloms sclerotic gloms
Total N
Case of gloms Microcysts TID 0–3% Arteriolosclerosis%
1a 89 45 (50.5) 44 (49.5) 1 31 2
2a 23 7 (30.4) 10 (43.4) 1 31 11
3a 17 9 (52.9) 4 (23.5) 2 31 11
4a 20 10 (50.0) 10 (50.0) 1 31 2
5a 13 5 (38.4) 1 (7.7) 1 31 2
6a 23 19 (82.6) 1 (4.3) 1 31 2
7a 10 4 (40.0) 1 (10.0) 1 31 2
8a 18 2 (11.1) 10 (55.5) 1 21 11
9b 10 2 (20.0) 2 (20.0) 1 21 11
10b 20 2 (10.0) 16 (80.0) 2 11 11
a Cases 1–8, HIV-associated nephropathy
b Cases 9 and 10, collapsing idiopathic glomerulopathy
Tubulointerstitial damage (TID) scores are: 0, 11 ,25%; 21 .25 but ,50%; 31 .50%. Arteriolosclerosis scores are: 0–11 5 mild, 21 5 moderate, 31 5
severe. Abbreviations are: segm, segmental; gloms, glomeruli.
ferentiate. Mature podocytes did not express Ki-67 (data Altered podocyte cell cycle protein expression in CG
not shown). The expression of cyclin A, an S-phase pro- We next analyzed the expression of CKI p57 and p27 in
moter, was observed only in 20% of the cells in the CG. During development, p57 and p27 show a reciprocal
S-shaped body stage. At the capillary loop stage and in pattern of expression compared with cyclin A [5] and
mature glomeruli, staining for cyclin A was absent (data are thought to render podocytes growth-arrested in the
adult [1, 5, 7]. The expression of p57 and p27 was lostnot shown). In contrast, cyclin D1 and CKI p57 and p27
in 69 and 62% of all glomeruli, respectively. The loss ofwere not expressed in the early stages of glomerular
p57 and p27 (in 1.0 and 0.8 podocytes per glomerulus)development, but became strongly positive in podocytes
was restricted to areas of collapse and pseudocrescentat the capillary loop stage and remained high in mature
formation, involving 60 to 100% of the podocytes overly-glomeruli (Fig. 2b, c).
ing the collapsed GBM (Figs. 2i and 3 a, b). In contrast
to synaptopodin (Fig. 2d) and cyclin D1 (Fig. 2e), expres-Concurrent loss of synaptopodin and cyclin D1 reflects
sion of p57 (Fig. 2f) and p27 (data not shown) werethe dysregulation of the podocyte phenotype
preserved in nonaffected glomeruli. Finally, we studied
In a recent study, we showed that loss of synaptopodin the expression of cyclin A and Ki-67. The proliferative
and WT-1 occurs not only in injured glomeruli but also activity of podocytes was assessed by Ki-67 expression.
in nonaffected ones, suggesting that podocyte phenotype While mature podocytes lacked expression of cyclin A
dysregulation plays an important role in the pathogenesis (data not shown) [5], de novo expression of cyclin A was
of CG [10]. In agreement with the latter study, synapto- observed in one to three podocytes per glomerulus in
podin expression was markedly reduced in 50% of nonaf- areas of glomerular injury in 11% of all glomeruli (with
fected glomeruli (ranging from 0 to 100% for each an average of 0.2 podocytes per glomerulus; Fig. 3c). No
biopsy), showing a weak, punctuated staining pattern Ki-67 expression was noted in normal adult kidney (data
not shown) [5–10], whereas in CG, 29% of all glomeruli(Fig. 2d). Synaptopodin expression was also strongly re-
showed one to five podocytes with nuclear expressionduced or absent in all segmentally and globally affected
of Ki-67 in areas of collapse (with an average of 0.8glomeruli (Fig. 2g). Cyclin D1 staining was negative in
podocytes per glomerulus; Fig. 3d). The lower propor-80% of the total number of glomeruli. Within the glomer-
tion of cyclin A-positive cells compared with Ki-67–uli showing a loss of cyclin D1 expression, the number
positive cells indicates that only a subpopulation of pro-of cyclin D1-negative podocytes varied between 50 and
liferating podocytes was in the S phase, where cyclin A100%, with an average number of 4.8 podocytes per
expression peaks [5]. The immunohistochemical resultsglomerulus. Similar to synaptopodin (Fig. 2d), cyclin D1
were virtually identical for both HIVAN and idiopathicwas also negative in few nonaffected glomeruli (Fig. 2e).
CG, and are summarized in Table 2.
Interestingly, loss or reduced expression of synaptopodin
(Fig. 2g) coincided with a loss of cyclin D1 expression
DISCUSSION(Fig. 2h). The simultaneous loss of synaptopodin and
cyclin D1 is reciprocal to the simultaneous and late ap- In a previous study, we have shown that in CG podo-
cytes undergo a dysregulation of their phenotype andpearance of both proteins during glomerulogenesis [6].
Fig. 2. Podocyte phenotype in normal adult
kidney and in early lesions of HIVAN. (Left
panels; a–c) Normal adult kidney. Synapto-
podin is strongly expressed in normal adult
podocytes, at the level of foot processes (a).
Nuclear expression of cyclin D1 (b) and p57
(c) is evident in podocyte. (Middle panels;
d–f ) CG, nonaffected glomerulus. Synapto-
podin expression is markedly reduced in non-
affected glomeruli of CG (d) with a weak
punctuated staining compared with a strong
linear staining seen in normal control (a).
Cyclin D1 (e) expression is loss in dysregu-
lated podocytes of nonaffected glomeruli
where nuclear immunostaining for p57 is still
present (f). (Right panels; g–i) CG (serial sec-
tions), segmental collapse. While immuno-
staining for synaptopodin (g) and cyclin D1
(h) is diffusely reduced or not detectable, loss
of p57 expression (i) is restricted to the area
of segmental collapse (arrowheads) but is pre-
served in nonaffected capillaries of the same
glomerulus. (a–c, g–i, 3100; d–f, 3120).
Fig. 3. Altered podocyte cell cycle and prolif-
eration in CG. Cyclin kinase inhibitor (CKI)
expression including p57 (a) and p27 (b) is
diffusely lost in globally affected glomeruli.
Note that Bowman’s space is completely filled
with podocytes. In areas of podocyte crowd-
ing, cyclin A (c) and Ki-67 (i) expression is
observed in podocytes (arrowheads in c and
d; 3120). (a and b) Serial sections. (a–d)
HIVAN.
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Table 2. Modulation of synaptopodin and cell cycle proteinproliferate in a “tumor cell-like fashion” [10]. In the
expression in collapsing glomerulopathics (CG)
present study, we confirmed and extended these findings
Synaptopodin Cyclin D1 p27 p57 Cyclin A Ki-67with respect to (1) the identification of cell cycle proteins
CG ###a ###a ### ### " ""involved in activation of podocyte proliferation in CG,
NAK 1 1 1 1 2 2(2) alterations of cell cycle protein expression, and (3)
NFK 2 2 2 2 1 1
the identification of cyclin D1 as a possible regulator of
Arrows are: " or # 5 1–25% of all glomeruli; "" or ## 5 26–50% of all glomeruli;podocyte differentiation. Moreover, the finding that the """ or ### 5 more than 50% of all glomeruli. Abbreviations are: NAK, normal
adult kidney; NFK, normal fetal kidney.changes of cell cycle protein expression were identical
a In CG expression of synaptopodin and cyclin D1 are reduced in affectedbetween HIV-associated and idiopathic CG further sup- and nonaffected glomeruli, whereas changes in p27, p57 and cyclin A and
Ki-67 expression are restricted to areas of collapseports the hypothesis that both diseases share a common
pathomechanism [10].
Several studies have shown that, in contrast to glomer-
ular endothelial and mesangial cells, the proliferative
crowding of podocytes). This loss of differentiation maycapacity of podocytes is restricted under normal and
be the tradeoff for the completion of cell division similarpathological conditions [5, 8]. The reduced proliferative
to that observed in cultured podocytes; in vitro podocytescapacity of podocytes in vivo may be the consequence
can exist in two different phenotypes: (1) undifferentiatedof CKI activity [1, 7]. Moreover, Shankland et al have
epithelial cobblestones with capability for replication butshown that in experimental membranous nephropathy,
lacking synaptopodin expression or (2) differentiatedp27 expression is dramatically increased in podocytes
growth-arrested arborized cells showing synaptopodin[16]. The increased CKI expression in podocytes injured
expression [17, 18].by hemodynamic stresses may explain the pathogenic
The present study has also shed some light on themechanism of sclerosis formation in secondary forms of
role of cyclin D1 as a possible regulator of podocytefocal segmental glomerulosclerosis, where injured podo-
differentiation. During kidney development, cyclin D1cytes, unable to replicate, are lost and cannot be replaced
expression is first detected in the capillary loop stagesby new cells [7]. The loss of podocytes may therefore
[5]. This is the stage in which podocytes become growthlead to areas of denuded basement membrane, synechiae
arrested, acquire their differentiated phenotype, andformation, and inevitable progression to segmental scle-
start to express synaptopodin [14]. In contrast, in CG,rosis [7]. In sharp contrast to the latter, we have demon-
both synaptopodin and cyclin D1 simultaneously disap-strated that in CG, a primary podocyte injury leads to
pear from nonaffected glomeruli (Fig. 2 d, e). In additionpodocyte proliferation and plays an important pathoge-
to G1 promotion, cyclin D1 may also be involved innetic role [10]. Crowding and proliferation of dysregu-
maintaining cell differentiation [19]. Based on the earlylated podocytes are evident on histologic examination
loss in GC and on the late appearance during glomerulo-and coincide with loss of p57 and p27 expression in the
genesis [5], it is tempting to speculate that cyclin D1 mayareas of collapse and pseudocrescent formation (Fig. 3a,
play a role in maintaining the differentiated podocyteb). This loss of CKI in CG may explain, at the molecular
phenotype. Recently, Sheaff et al showed that cyclin E1,level, the mechanism whereby podocytes replicate. On
which can rescue cyclin D1 deficiency and functionallythe other hand, the expression of CKI was maintained
replace cyclin D1 [20], is a regulator of p27 [21]; hencein nonaffected glomerular capillaries (Fig. 2f) despite
cyclin D1 and cyclin E1 may have similar functions. Fur-the dysregulation of the podocyte phenotype reflected
ther studies are required to test whether cyclin D1 isby the lack of synaptopodin and cyclin D1 (Fig. 2d, e).
directly involved in regulating the expression or activityThe preservation of CKI expression in noncollapsed
of p27 and p57 in podocytes.areas but the absence in areas of collapse and podocyte
Both HIVAN and idiopathic CG share not only similarhyperplasia suggest that the activation and completion
morphologic features but also a common pathogeneticof podocyte cell division in CG is a two-step process.
mechanism [10]. In both forms of CG, podocytes showThe first step of this process is characterized by the disap-
a dysregulated phenotype, re-entry of the cell cycle, andpearance of synaptopodin and cyclin D1 (Fig. 2d, e).
proliferation. Similar findings are seen in a transgenicThe parallel loss of synaptopodin and cyclin D1 further
mouse model of HIVAN [22]. The HIV transgene hascorroborates the hypothesis that CG is a primary podo-
been detected in podocytes in the early phases of thecyte disease. This loss represents the first molecular man-
disease. In the late stages, when the glomerular and po-ifestation of the disease at a point in which the histologic
docyte damage becomes morphologically evident, thefindings in the glomerulus are still normal [10]. The sec-
viral genome expression has decreased and is followedond step of this process occurs in the histologically af-
by podocyte phenotype dysregulation. These findingsfected areas and is characterized by the cell cycle re-
suggest that a direct viral infection may account for theentry of podocytes, re-expression of cyclin A and Ki-67,
loss of CKI expression, and cell replication (reflected by podocyte alterations in HIVAN [22]. Interestingly, Co-
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cycle regulation and differentiation in the human podocyte lineage.hen et al detected HIV-DNA incorporation in podocytes
Am J Pathol 153:1511–1520, 1998
by in situ hybridization [23]. However, so far, the pres- 6. Combs HL, Shankland SJ, Setzer SV, Hudkins KL, Alpers CE:
Expression of the cyclin kinase inhibitor, p27kip1, in the developingence of specific receptors in podocytes has not been dem-
and mature human kidney. Kidney Int 53:892–896, 1998onstrated. If the HIV infection of podocytes may explain
7. Mundel P, Shankland SJ: Glomerular podocytes and adhesive
the pathologic alterations in podocytes in HIVAN, the interaction with glomerular basement membrane. Exp Nephrol
7:160–166, 1999etiology of idiopathic CG still remains to be explained.
8. Kriz W, Ha¨hnel B, Ro¨sener S, Elger M: Long-term treatmentAn undetected viral infection has been postulated to be
of rats with FGF-2 results in focal segmental glomerulosclerosis.
responsible for the glomerular disease [12, 13]. Further Kidney Int 48:1435–1450, 1995
9. Shankland SJ, Al’Douahji M: Cell cycle regulatory proteins instudies are required to answer this interesting question.
glomerular disease. Exp Nephrol 7:207–211, 1999In summary, the present study confirmed and extended
10. Barisoni L, Kriz W, Mundel P, D’Agati V: The dysregulated
our previous observation that CG is a unique pathologi- podocyte phenotype: A novel concept in the pathogenesis of col-
lapsing idiopathic focal segmental glomerulosclerosis and HIV-cal entity, in which podocytes dedifferentiate early in
associated nephropathy. J Am Soc Nephrol 10:51–61, 1999the course of the disease and lose both synaptopodin 11. Pardo V, Aldana M, Colton RM, Fischl MA, Jaffe D, Mosko-
and cyclin D1 expression. While the phenotypic dysregu- witz L, Hensley GT, Bourgoignie JJ: Glomerular lesions in the
acquired immunodeficiency syndrome. Ann Intern Med 101:429–lation is a diffuse process occurring in both affected and
434, 1984histologically normal glomeruli, loss of CKI p27 and p57 12. Detwiler RK, Falk RJ, Hogan SL, Jennette JC: Collapsing glom-
and re-expression of cyclin A are restricted to areas of erulopathy: A clinically and pathologically distinct variant of focal
segmental glomerulosclerosis. Kidney Int 45:1416–1424, 1994severe morphologic damage. As a consequence of cell
13. Valeri A, Barisoni L, Appel GB, Seigle R, D’Agati V: Idiopathiccycle re-entry, podocytes override the restriction points collapsing focal segmental glomerulosclerosis: A clinocopathologi-
cal study. Kidney Int 1996:1734–1746, 1996of cell cycle control and proliferate, leading to pseu-
14. Mundel P, Gilbert P, Kriz W: Podocytes in glomerulus of ratdocrescent formation and compression of the glomerular
kidney express a characteristic 44 kD protein. J Histochem Cyto-
tuft. Future studies will focus on analyzing the role of chem 39:1047–1056, 1991
15. Mundel P, Heid HW, Mundel TM, Kruger M, Reiser J, Krizcyclin D1 in podocyte differentiation and identifying the
W: Synaptopodin: An actin-associated protein in telencephalicexternal stimuli responsible for deranging the podocyte
dendrites and renal podocytes. J Cell Biol 139:193–204, 1997
cell cycle in CG. 16. Shankland SJ, Floege J, Thomas SE, Nanguku M, Hugo C,
Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG:
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